- Hypertrophic Cardiomyopathy (HCM)
- Eyecare
- Urothelial Carcinoma
- Hemophilia
- Heart Failure
- Vaccines
- Neonatal Care
- NSCLC
- Type II Inflammation
- Substance Use Disorder
- Gene Therapy
- Lung Cancer
- Spinal Muscular Atrophy
- HIV
- Post-Acute Care
- Liver Disease
- Asthma
- Atrial Fibrillation
- COVID-19
- Cardiovascular Diseases
- Prescription Digital Therapeutics
- Reproductive Health
- The Improving Patient Access Podcast
- Blood Cancer
- Ulcerative Colitis
- Respiratory Conditions
- Multiple Sclerosis
- Digital Health
- Population Health
- Sleep Disorders
- Biosimilars
- Plaque Psoriasis
- Leukemia and Lymphoma
- Oncology
- Pediatrics
- Urology
- Obstetrics-Gynecology & Women's Health
- Opioids
- Solid Tumors
- Autoimmune Diseases
- Dermatology
- Diabetes
- Mental Health
FAQs: AmeriHealth Mercy acquisition
On August 9, Independence Blue Cross and Blue Cross Blue Shield of Michigan announced their alignment
Q: Who bought AmeriHealth Mercy?
A: Independence Blue Cross (IBC) and Blue Cross Blue Shield of Michigan (BCBSM) are now co-owners of AmeriHealth Mercy, with IBC owning 60% and BCBSM owning 40%.
Q: Who initially had ownership of AmeriHealth Mercy?
Q: What will happen with Mercy Health Plan's interest in Amerihealth Mercy?
A: Mercy Health Plan will be paid $170 million for its 50% ownership interest. BCBSM will acquire a minority interest in AmeriHealth Mercy. Furthermore, the Mercy Health Foundation will receive a series of contributions over a period of seven years.
Q: What appeal does AmeriHealth Mercy and this partnership create?
A: AmeriHealth Mercy has operational and care capabilities and is one of the country's largest Medicaid companies. The partnership investment will help the Blues establish a national presence in the Medicaid market. It also can help pioneer new ways of doing business that will enhance the health and wellness of the people and communities served.
Q: What additional services and benefits would this partnership produce?
A: AmeriHealth Mercy currently offers pharmacy benefits management and behavioral healthcare to 3.2 million Medicaid, Medicare and SCHIP beneficiaries in 11 states. The partnership will allow AmeriHealth Mercy to become better positioned to offer turnkey, cost-effective, comprehensive Medicaid managed care coverage and services nationwide.
Q: What is Medicaid managed care?
A: It is designed to provide quality health care at a lower cost than fee-for-service Medicaid. Due to current budget distress in the government, many states may turn to Medicaid managed care.
Q: Who is the executive at IBC?
A: In 2010, Daniel J Hilferty transitioned to IBC president and CEO after serving at AmeriHealth Mercy for 13 years in the same capacity.
Q: Who is the executive at BCBSM?
A: BCBSM's president and CEO is Daniel J Leopp
Q: Who is the executive at AmeriHealth Mercy?
A: Michael A Rashid is president and CEO.
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen
Air Pollution May Negatively Affect Male Reproductive Health
November 30th 2023A potential mechanism by which air pollutants may affect reproductive health is by endocrine disruption. Air pollutants are made up of mixtures of particulate matter that may include endocrine disruptors, such as polycyclic aromatic hydrocarbons (PAHs) and heavy metals.
Read More
35th World AIDS Day Marks 20 Years of PEPFAR: Challenges and Strategies to Combat HIV/AIDS
November 29th 2023PEPFAR, having invested $100 billion and saved 25 million lives in the global fight against HIV/AIDS, faces Congressional hurdles in its reauthorization due to abortion debates. Despite widespread support and no evidence of abortion-related activities, the legislative process is at a standstill. Members of PEPFAR and authors of a recent editorial stress the significance of PEPFAR and advocate for integrating behavioral and social science into healthcare programs to achieve UNAIDS targets and address barriers in HIV/AIDS testing and treatment.
Read More
